T2DM patients

This study was a randomized, open-label, parallel-group clinical trial in TDM patients with a week treatment period.本研究为一项针对治疗药物监测（Therapeutic Drug Monitoring，TDM）患者的随机、开放标签、平行组临床试验，治疗周期为一周。